Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The prevention and management of Crohn's disease postoperative recurrence: results from the Y-ECCO/ClinCom 2019 Survey

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Enhanced processing of von Willebrand factor reflects disease severity and discriminates severe portal hypertension in cirrhosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Challenges and obstacles in the transition process through the eyes of the gastroenterologist

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Outcome and adverse events in patients with chronic hepatitis C treated with direct-acting antivirals: A clinical randomized study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Clinical Research Committee (ClinCom) of ECCO and Young ECCO Committee (Y-ECCO)
View graph of relations

BACKGROUND: Prevention and management of postoperative recurrence (POR) is a controversial field in Crohn's disease. The aim of this survey was to report common practice in real-life settings.

METHODS: An 11-question survey was distributed among gastroenterologists attending the 14th European Crohn's and Colitis Organisation (ECCO) congress.

RESULTS: Postoperative endoscopy to assess recurrence was routinely performed within 12 months by 87% of respondents. Forty-six percent of clinicians reported to maintain endoscopic assessment in routine follow-up even after first negative colonoscopy. Most respondents (60%) considered starting postoperative immunoprophylaxis in naïve patients if one or more known risk factors were present. The number of risk factors was an important driver for prescribing biologics over immunosuppressants for 60% of respondents.In case of fistulizing phenotype, perianal disease, or concomitant colonic involvement, the majority of physicians reported to start an immediate prophylaxis in 85, 98 and 88% of patients, respectively. A significant percentage of clinicians were more prone to an endoscopy-driven treatment in long-standing disease after failure of thiopurines (51%) and elderly (43%).

CONCLUSION: Endoscopy within the first year after surgery to assess POR has become routine in most centres. The high rate of early prophylaxis with expensive biologics despite missing solid evidence highlights the need for more randomized trials.

Original languageEnglish
JournalEuropean journal of gastroenterology & hepatology
Volume32
Issue number8
Pages (from-to)1062-1066
Number of pages5
ISSN0954-691X
DOIs
Publication statusPublished - Aug 2020

    Research areas

  • biologics, Crohn's disease, immunoprophylaxis, postoperative recurrence, prevention

ID: 59661551